Health technology platform Tata 1mg steps up diagnostics play

Since Tata 1mg is focused on online diagnostics and home collection of samples, it has third-party partners for radiology tests

Health technology platform Tata 1mg, one of the early movers in online diagnostics, is slowly building its presence in the space after rival PharmEasy acquired national diagnostics chain Thyrocare last year.

Tata 1mg, previously 1mg, which started its diagnostics services in 2016, now draws 15 per cent of its revenues from this vertical. Gaurav Agrawal, co-founder, Tata 1mg, said the diagnostics business was more profitable than the online pharmacy business. However, he did not share the revenue break-up and margins.

“We have a collection and logistics brand, Droplets. But slowly we are integrating our entire diagnostics offering under the Tata 1mg Diagnostics